AnaptysBio ANAB

$ 21.25 4.63%

Quarterly report 2024-Q3
added 11-05-2024

AnaptysBio Balance Sheet 2011-2024 | ANAB

Annual Balance Sheet AnaptysBio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-18.2 M	-51.9 M	-475 M	-	-170 M	-105 M	-66.8 M	-37.4 M	-46.8 M	-17.4 M	-1.99 M	-	-
Long Term Debt	16 M	17.8 M	19.4 M	-	-	625 K	7.55 M	13.8 M	4.9 M	4.79 M	-	-	-
Long Term Debt Current	1.78 M	1.64 M	1.5 M	342 K	871 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	654 K	796 K	7.69 M	17.2 M	6.57 M	7.39 M	607 K	-	-
Total Current Liabilities	37.4 M	26.1 M	16.1 M	19.8 M	29.5 M	21.8 M	14.1 M	-	-	-	-	-	-
Total Liabilities	-	-	-	-	30.2 M	22.6 M	21.8 M	22.9 M	13.9 M	19.1 M	3.77 M	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	2.94 M	10.1 M	1.29 M	-	-
Retained Earnings	-614 M	-450 M	-322 M	-264 M	-244 M	-147 M	-85 M	-54.9 M	-50.7 M	-45.3 M	-48.8 M	-	-
Total Assets	452 M	610 M	643 M	417 M	435 M	509 M	329 M	62.2 M	56.3 M	25.1 M	3.91 M	-	-
Cash and Cash Equivalents	36 M	71.3 M	496 M	251 M	171 M	114 M	81.2 M	51.3 M	51.7 M	-	-	-	-
Book Value	452 M	610 M	643 M	417 M	405 M	486 M	308 M	39.3 M	42.3 M	5.99 M	145 K	-	-
Total Shareholders Equity	88.1 M	262 M	356 M	397 M	405 M	486 M	308 M	-38.2 M	-35.2 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet AnaptysBio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	14.6 M	15.1 M	15.6 M	16 M	16.5 M	16.9 M	17.4 M	17.8 M	18.2 M	18.7 M	19.1 M	19.4 M	19.8 M	20.2 M	-	-	-	-	419 K	654 K	654 K	654 K	654 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-738 M	-705 M	-658 M	-614 M	-572 M	-535 M	-495 M	-450 M	-424 M	-391 M	-358 M	-322 M	-289 M	-283 M	-282 M	-264 M	-264 M	-264 M	-264 M	-244 M	-244 M	-244 M	-244 M	-147 M	-147 M	-147 M	-147 M	-85 M	-85 M	-85 M	-85 M	-54.9 M	-54.9 M	-54.9 M	-54.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	493 M	427 M	406 M	452 M	487 M	517 M	552 M	610 M	619 M	604 M	625 M	643 M	424 M	427 M	396 M	417 M	417 M	417 M	417 M	435 M	435 M	435 M	435 M	509 M	509 M	509 M	509 M	329 M	329 M	329 M	329 M	62.2 M	62.2 M	62.2 M	62.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	192 M	71.8 M	53.7 M	36 M	26.3 M	35.2 M	94.6 M	71.3 M	58.5 M	71.7 M	166 M	496 M	336 M	332 M	284 M	251 M	250 M	250 M	250 M	171 M	171 M	171 M	171 M	114 M	114 M	114 M	114 M	81.2 M	81.2 M	81.2 M	81.2 M	51.2 M	51.2 M	51.2 M	51.2 M	51.7 M	-	-	-	22.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	493 M	427 M	406 M	452 M	487 M	517 M	552 M	610 M	619 M	604 M	625 M	643 M	424 M	427 M	396 M	417 M	417 M	417 M	417 M	435 M	435 M	435 M	435 M	509 M	509 M	509 M	509 M	329 M	329 M	329 M	329 M	62.2 M	62.2 M	62.2 M	62.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	84.4 M	9.88 M	47.8 M	88.1 M	120 M	148 M	191 M	262 M	278 M	304 M	331 M	356 M	384 M	386 M	382 M	397 M	397 M	397 M	397 M	405 M	405 M	405 M	405 M	486 M	486 M	486 M	486 M	308 M	308 M	308 M	308 M	-38.2 M	-38.2 M	-38.2 M	-38.2 M	-35.2 M	-	-	-	-30.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency